2021
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
HOENIGL, M., J. SALMANTON-GARCIA, T. J. WALSH, M. NUCCI, C. F. NEOH et. al.Základní údaje
Originální název
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
Autoři
HOENIGL, M. (garant), J. SALMANTON-GARCIA, T. J. WALSH, M. NUCCI, C. F. NEOH, J. D. JENKS, M. LACKNER, R. SPRUTE, A. M. S. AL-HATMI, M. BASSETTI, F. CARLESSE, Tomáš FREIBERGER (203 Česká republika, domácí), P. KOEHLER, T. LEHRNBECHER, A. KUMAR, J. PRATTES, M. RICHARDSON, S. REVANKAR, M. A. SLAVIN, J. STEMLER, B. SPIESS, S. J. TAJ-ALDEEN, A. WARRIS, P. C. Y. WOO, J. A. H. YOUNG, K. ALBUS, D. ARENZ, V. ARSIC-ARSENIJEVIC, J. P. BOUCHARA, T. R. CHINNIAH, A. CHOWDHARY, G. S. DE HOOG, G. DIMOPOULOS, R. F. DUARTE, P. HAMAL, J. F. MEIS, S. MFINANGA, F. QUEIROZ-TELLES, T. F. PATTERSON, G. RAHAV, T. R. ROGERS, C. ROTSTEIN, R. WAHYUNINGSIH, D. SEIDEL a O. A. CORNELY
Vydání
Lancet Infectious Diseases, Oxford, Elsevier SCI LTD, 2021, 1473-3099
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30303 Infectious Diseases
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 71.421
Kód RIV
RIV/00216224:14110/21:00123978
Organizační jednotka
Lékařská fakulta
UT WoS
000680046200004
Klíčová slova anglicky
rare mould infections; diagnosis; management
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 29. 3. 2022 12:42, Mgr. Tereza Miškechová
Anotace
V originále
With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World-One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.